BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 11861412)

  • 21. Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.
    Fernández-Varo G; Morales-Ruiz M; Ros J; Tugues S; Muñoz-Luque J; Casals G; Arroyo V; Rodés J; Jiménez W
    J Hepatol; 2007 Mar; 46(3):440-6. PubMed ID: 17156884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular extracellular matrix in atherosclerosis.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.
    Vacek TP; Rehman S; Neamtu D; Yu S; Givimani S; Tyagi SC
    Vasc Health Risk Manag; 2015; 11():173-83. PubMed ID: 25767394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of blood flow-induced vascular enlargement.
    Lehoux S; Tronc F; Tedgui A
    Biorheology; 2002; 39(3-4):319-24. PubMed ID: 12122247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
    Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
    J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular proteolysis in the development and progression of atherosclerosis.
    Lijnen HR
    Biochem Soc Trans; 2002 Apr; 30(2):163-7. PubMed ID: 12023844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme and vascular remodeling.
    Heeneman S; Sluimer JC; Daemen MJ
    Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischaemia and reperfusion.
    Wainwright CL
    Curr Opin Pharmacol; 2004 Apr; 4(2):132-8. PubMed ID: 15063356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small artery remodeling: current concepts and questions.
    van den Akker J; Schoorl MJ; Bakker EN; Vanbavel E
    J Vasc Res; 2010; 47(3):183-202. PubMed ID: 19893316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology of metalloproteinases.
    Amălinei C; Căruntu ID; Bălan RA
    Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
    Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
    J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases in atherothrombosis.
    Bäck M; Ketelhuth DF; Agewall S
    Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
    Schäfers M; Schober O; Hermann S
    J Nucl Med; 2010 May; 51(5):663-6. PubMed ID: 20439506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases in metabolic syndrome.
    Hopps E; Caimi G
    Eur J Intern Med; 2012 Mar; 23(2):99-104. PubMed ID: 22284236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases and diabetic vascular complications.
    Kadoglou NP; Daskalopoulou SS; Perrea D; Liapis CD
    Angiology; 2005; 56(2):173-89. PubMed ID: 15793607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of matrix metalloproteinases in vascular remodeling.
    Kuzuya M; Iguchi A
    J Atheroscler Thromb; 2003; 10(5):275-82. PubMed ID: 14718744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.